Terveystalo (HLSE:TTALO) Q3 Results Deepen Margin Squeeze And Debt Concerns

Terveystalo Oyj walked into its Q3 2026 earnings with the share price already under pressure, down about 19% over the past month and closing at €6.27 on 22 October. The headline this quarter is not revenue of €263.2m or basic earnings per share of €0.04. The real story is the profit squeeze. Net income from continuing operations fell to €5.5m, compressing margins and putting fresh scrutiny on a business that screens cheap on P/E and discounted cash flow models but carries high debt and a dividend that strains current earnings.

Love that Terveystalo Oyj screens cheap on P/E yet worried about the debt load and a dividend that leans hard on thin earnings? Benchmark those trade offs against stocks in our list of solid balance sheet and fundamentals stocks (203 results)

Q3 2026 Earnings Summary

• Revenue (Q3 2026 vs Q3 2025): €263.2m vs. €280.4m (down about 6%)
• Net Income from Continuing Operations (Q3 2026 vs Q3 2025): €5.5m vs. €16.2m (fell about 66%)
• Basic EPS (Q3 2026 vs Q3 2025): €0.04 vs. €0.13 (declined about 69%)
• Net Profit Margin, Trailing 12 Months (latest vs prior year): 4.8% vs. 7.0% (compressed by 2.2 percentage points)

Ask Charlie what Terveystalo’s ARC pivot really changes.

Terveystalo bullish growth story under pressure test

The upbeat story says new services and channels should steadily lift revenue quality and profitability for Terveystalo.

"Expansion into new public and private healthcare initiatives, as well as high-demand segments, positions the company for sustainable revenue growth and margin enhancement."

Q3 shows some groundwork but not yet the pay-off. Dental grew and Hohde added roughly €5.5m to €6.2m of sales, yet group revenue still fell about 6% and net profit margin on a trailing 12 month view sits at 4.8%, below 7.0% a year earlier. Margin enhancement remains a missed milestone for now.

Bearish execution risks surface in Q3 Terveystalo print

Sceptics focus on execution risk and whether cost savings and tech projects arrive fast enough to offset weak demand and higher wages.

"Labor cost inflation and workforce shortages, evident in the need for efficiency improvements and technology investment, could drive up the fixed cost base and compress operating margins, especially if demand remains subdued or shifts more rapidly to lower-margin telehealth services than the company can offset with efficiency gains."

Q3 results lean toward this concern. Revenue declined and adjusted EBIT fell as operating leverage turned negative even though variable costs were cut quickly. Management lowered full year adjusted operating profit guidance to €110m to €120m, which indicates efficiency efforts are not yet fully cushioning the weaker volume environment.

That disagreement has a full argument behind it. → Uncover the higher Fair Value this Narrative argues for.

Hunt For Mispriced Earnings Power

Terveystalo Oyj’s squeezed quarter shows how vulnerable an earnings story becomes when margins weaken. The real opportunity is finding stocks that could be undervalued before the market corrects them.

• Company 1 - 35% below our estimate - secures contracted offshore work as support vessels become scarce while older fleets retire.
• Company 2 - 30% below our estimate - shifts production toward higher margin composite and clean energy lines as automated capacity starts operating.
• Company 3 - 44% below our estimate - expands long term service agreements that turn installed equipment into recurring maintenance and spare parts revenue.

Those are three of them. See every one of the 191 undervalued companies on it →

Have feedback on this article? Concerned about the content? Get in touch with us directly. Alternatively, email editorial-team@simplywallst.com